NATIONAL TUBEROUS SCLEROSIS ASSOCIATION INC: Form 990, tax year 2023

View the entire original 990 at ProPublica ↗

Organization
NATIONAL TUBEROUS SCLEROSIS ASSOCIATION INC (EIN 95-3018799)
Tax period
2023-01-01 to 2023-12-31
Filed
2024-09-24
IRS object ID
202432689349301018
Schema version
2023v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2024-09-24T12:54:15-05:00ReturnTs
Tax Period End2023-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN470900880PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CALIBRE CPA GROUP PLLCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line17501 WISCONSIN AVENUE SUITE 1200AddressLine1Txt
Address Line2WESTAddressLine2Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP20814ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2023-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN953018799EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1NATIONAL TUBEROUS SCLEROSISBusinessNameLine1Txt
Business Name Line2ASSOCIATIONBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlNATIBusinessNameControlTxt
Phone3015629890PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line18737 COLLESVILLE ROAD 400AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonKARI L ROSBECKPersonNm
Person TitlePRESIDENT & CEOPersonTitleTxt
Phone3015629890PhoneNum
Signature2024-09-17SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd
FieldValueIRS element (for citing)
IRS Responsible Prty Info CurrYes (1)IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonKRISTIN A JACQUELIN CPAPreparerPersonNm
PTINP01325865PTIN
Phone2023319880PhoneNum
Preparation2024-09-24PreparationDt
FieldValueIRS element (for citing)
Tax2023TaxYr
Build TS2024-08-08 14:25:15ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Amended ReturnYes (X)AmendedReturnInd

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1TSC ALLIANCEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerKARI L ROSBECKPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line18737 COLLESVILLE ROAD 400AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$10,180,515GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.TSCALLIANCE.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1975FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionTO IMPROVE QUALITY OF LIFE FOR EVERYONE AFFECTED BY TUBEROUS SCLEROSIS COMPLEX BY CATALYZING NEW TREATMENTS, DRIVING RESEARCH TOWARD A CURE AND EXPANDING ACCESS TO LIFELONG SUPPORT.ActivityOrMissionDesc
Voting Members Governing Body30VotingMembersGoverningBodyCnt
Voting Members Independent30VotingMembersIndependentCnt
Total Employee26TotalEmployeeCnt
Total Volunteers2234TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$7,016,851PYContributionsGrantsAmt
CY Contributions Grants$6,747,948CYContributionsGrantsAmt
PY Program Service Revenue$2,720,317PYProgramServiceRevenueAmt
CY Program Service Revenue$2,815,353CYProgramServiceRevenueAmt
PY Investment Income$2,636PYInvestmentIncomeAmt
CY Investment Income$36,732CYInvestmentIncomeAmt
PY Other Revenue-$830,262PYOtherRevenueAmt
CY Other Revenue$416,350CYOtherRevenueAmt
PY Total Revenue$8,909,542PYTotalRevenueAmt
CY Total Revenue$10,016,383CYTotalRevenueAmt
PY Grants And Similar Paid$1,032,155PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$845,292CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$2,896,346PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$3,024,376CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,150,291CYTotalFundraisingExpenseAmt
PY Other Expenses$4,135,183PYOtherExpensesAmt
CY Other Expenses$4,597,980CYOtherExpensesAmt
PY Total Expenses$8,063,684PYTotalExpensesAmt
CY Total Expenses$8,467,648CYTotalExpensesAmt
PY Revenues Less Expenses$845,858PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$1,548,735CYRevenuesLessExpensesAmt
Total Assets BOY$14,827,937TotalAssetsBOYAmt
Total Assets EOY$16,085,768TotalAssetsEOYAmt
Total Liabilities BOY$2,373,091TotalLiabilitiesBOYAmt
Total Liabilities EOY$2,088,420TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$12,454,846NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$13,997,348NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTO IMPROVE QUALITY OF LIFE FOR EVERYONE AFFECTED BY TUBEROUS SCLEROSIS COMPLEX BY CATALYZING NEW TREATMENTS, DRIVING RESEARCH TOWARD A CURE AND EXPANDING ACCESS TO LIFELONG SUPPORT.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$5,022,281ExpenseAmt
Grant$845,292GrantAmt
Revenue$2,621,353RevenueAmt
DescRESEARCH PROGRAM STIMULATES AND SUPPORTS BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH ON THE VARIOUS MANIFESTATIONS OF TUBEROUS SCLEROSIS COMPLEX (TSC) TO FURTHER THE DEVELOPMENT OF CLINICAL THERAPIES AND, ULTIMATELY, A CURE FOR TSC. DIRECTED BY STEVEN L. ROBERDS, PHD, CHIEF SCIENTIFIC OFFICER, THE TSC ALLIANCE RESEARCH PROGRAM BUILDS AND FOSTERS COLLABORATIONS BETWEEN BASIC AND CLINICAL RESEARCHERS BY COLLECTING AND DISTRIBUTING TSC NATURAL HISTORY DATA AND BIOSAMPLES, THROUGH COLLABORATIVE PRECLINICAL AND CLINICAL RESEARCH PROGRAMS, AND BY HOSTING BIENNIAL INTERNATIONAL TSC RESEARCH CONFERENCES.SINCE 1984, THE TSC ALLIANCE HAS INVESTED MORE THAN $37 MILLION INTO TSC RESEARCH PROJECTS THROUGH GRANTS AND CONTRACTS: $20.6 MILLION IN RESEARCH GRANTS AND POSTDOCTORAL FELLOWSHIPS, $5.3 MILLION INTO THE NATURAL HISTORY DATABASE AND BIOSAMPLE REPOSITORY, $9.6 MILLION INTO THE PRECLINICAL CONSORTIUM, AND $1.6 MILLION INTO THE CLINICAL RESEARCH CONSORTIUM. GRANT AND FELLOWSHIP APPLICATIONS ARE REVIEWED IN A THREE-STEP PROCESS: (1) ALL APPLICATIONS ARE REVIEWED BY A COMMITTEE COMPRISED OF SCIENTISTS KNOWLEDGEABLE ABOUT THE TOPIC AREA FOR SCIENTIFIC MERIT AND OF CAREGIVERS OR ADULTS AFFECTED BY TSC FOR POTENTIAL IMPACT ON THE LIVES OF THOSE AFFECTED BY TSC; (2) THE SCIENCE AND MEDICAL COMMITTEE OF THE BOARD OF DIRECTORS EVALUATES THE GRANT REVIEW COMMITTEE'S RECOMMENDATIONS AND THE RELEVANCE OF THE APPLICATIONS TO THE TSC ALLIANCE'S FUNDING PRIORITIES; AND (3) THE BOARD OF DIRECTORS THEN REVIEWS THE RECOMMENDATIONS OF THE SCIENCE AND MEDICAL COMMITTEE AND MAKES FINAL APPROVAL FOR FUNDING. FOR A COMPLETE LIST OF CURRENTLY FUNDED PROJECTS AND AN ARCHIVE OF PAST AWARDEES, PLEASE VISIT TSCALLIANCE.ORG/GRANTS.IN 2023, THE TSC ALLIANCE HOSTED OUR BIENNIAL INTERNATIONAL TSC RESEARCH CONFERENCE: FUELING THE FUTURE. FIFTEEN PERCENT OF ATTENDEES SELF-IDENTIFIED AS MEMBERS OF GROUPS HISTORICALLY UNDERREPRESENTED IN BIOMEDICAL RESEARCH. THE CONFERENCE FEATURED AN EARLY CAREER RESEARCH SYMPOSIUM, A KEYNOTE SPEECH FROM DR. MARTINA BEBIN, 30 ORAL PRESENTATIONS, 59 POSTERS, A TSC INTERNATIONAL WORKSHOP, AND A COMBINED CLOSING SESSION WITH TSC & LAM REGIONAL CONFERENCE PARTICIPANTS. THE CONFERENCE ALSO FEATURED FOUR BREAKOUT WORKING GROUP SESSIONS (TRANSITION FROM PEDIATRIC TO ADULT, NEURODEVELOPMENT AND EARLY INTERVENTION, CELLULAR ENERGETICS AND METABOLISM, AND BIG DATA AND SINGLE CELL APPROACHES/ANALYSIS) TO ALLOW TIME FOR ATTENDEES TO MEET WITH OTHERS IN THEIR FIELD AND WORK TOWARD SOLUTIONS FOR CURRENT ISSUES IN THEIR AREA.IMPLEMENTED IN 2006, THE TSC NATURAL HISTORY DATABASE (NHD) CAPTURES CLINICAL DATA TO DOCUMENT THE IMPACT OF THE DISEASE ON A PERSON'S HEALTH OVER HIS/HER LIFETIME. THE DATABASE SERVES AS A RESOURCE OF INFORMATION THAT HELPS TSC RESEARCHERS BETTER UNDERSTAND THE PROGRESSION OF THE DISEASE, DESIGN HYPOTHESIS-DRIVEN QUESTIONS TO HASTEN THE DISCOVERY OF NEW TREATMENTS AND IDENTIFY PERSONS WITH TSC WHO ARE ELIGIBLE TO PARTICIPATE IN RESEARCH STUDIES. AS OF DECEMBER 2023, 2,678 PEOPLE WITH TSC WERE ENROLLED IN THE PROJECT FROM AMONG 22 TSC CLINIC SITES AND THROUGH THE TSC ALLIANCE. THE TSC ALLIANCE PROVIDES FUNDING TO PARTICIPATING CLINICS TO PERFORM DATA ENTRY, MONITORS THE INTEGRITY OF THE DATABASE, AND MAKES DATA AVAILABLE TO INVESTIGATORS TO ANSWER SPECIFIC RESEARCH QUESTIONS AND IDENTIFY POTENTIAL PARTICIPANTS FOR CLINICAL TRIALS AND STUDIES BUILDING UPON THE NATURAL HISTORY DATABASE, THE TSC BIOSAMPLE REPOSITORY IS A TSC ALLIANCE-DIRECTED PROJECT INITIATED IN 2014 THAT WILL IMPACT RESEARCH OVER THE NEXT 10 YEARS OR MORE. THE TSC ALLIANCE'S SCIENCE AND MEDICAL COMMITTEE IDENTIFIED THIS AS A GAP THAT CAN ONLY BE FILLED EFFECTIVELY WITH LEADERSHIP OF THE TSC ALLIANCE, GUIDED BY A STEERING COMMITTEE OF CLINICIANS AND RESEARCHERS. HIGH-QUALITY BIOSAMPLES SUCH AS BLOOD, DNA, AND TISSUES LINKED TO DETAILED CLINICAL DATA ARE CRITICAL FOR RESEARCHERS TO UNDERSTAND WHY TSC IS SO DIFFERENT FROM PERSON TO PERSON. SAMPLES IN THE REPOSITORY ARE LINKED TO DETAILED CLINICAL DATA IN OUR EXISTING TSC NATURAL HISTORY DATABASE AND ARE AVAILABLE TO QUALIFIED RESEARCHERS WORLDWIDE. SAMPLES ARE HOUSED AT AND DISTRIBUTED FROM THE VAN ANDEL INSTITUTE IN GRAND RAPIDS, MI, UNDER CONTROL OF THE TSC ALLIANCE. AS OF DECEMBER 31, 2023, THE TSC BIOSAMPLE REPOSITORY HAS ACQUIRED 2,654 BIOSAMPLES: 1012 BLOOD SAMPLES FROM INDIVIDUALS WITH TSC ENROLLED IN THE NHD, 452 BUCCAL SAMPLES FROM INDIVIDUALS WITH TSC ENROLLED IN THE NHD, 197 TISSUE SAMPLES FROM INDIVIDUALS WITH TSC ENROLLED IN THE NHD, 591 BLOOD SAMPLES FROM THE TSC CLINICAL RESEARCH CONSORTIUM COLLABORATIVE PROJECTS, 389 DNA SAMPLES FROM THE TSC AUTISM CENTER OF EXCELLENCE NETWORK AUTISM BIOMARKER STUDY, AND 10 CONTROL SAMPLES. THE ORGANIZATION CONTINUES TO GROW THE BIOSAMPLE REPOSITORY BY COLLECTING BLOOD SAMPLES ANNUALLY FROM PARTICIPANTS WHO VOLUNTEER TO DO SO, ENABLING RESEARCHERS TO STUDY CHANGES IN PROTEINS AND OTHER MOLECULES IN THE BLOOD OVER TIME; ADDING ADDITIONAL TSC CLINICS AS PARTICIPATING BIOSAMPLE REPOSITORY COLLECTION SITES; AND COLLECTING BLOOD USING MOBILE PHLEBOTOMY, ENABLING PEOPLE TO DONATE SAMPLES REGARDLESS OF WHERE THEY LIVE IN THE US AND WHETHER THEY ARE SEEN AT A TSC CLINIC. SINCE THE INCEPTION OF OUR MOBILE PHLEBOTOMY INITIATIVE, WE HAVE ACQUIRED 473 BLOOD SAMPLES VIA MOBILE PHLEBOTOMY. TO ENCOURAGE AND ENABLE MORE RESEARCHERS TO UTILIZE BIOSAMPLES, THE TSC ALLIANCE AWARDED THREE SEED GRANTS IN 2023, TOTALING $60,000, TO LABS THAT SUBMITTED MERITORIOUS AND INNOVATIVE IDEAS FOR RESEARCH ON TSC BIOSAMPLES.THE TSC ALLIANCE'S WHOLE-GENOME SEQUENCING (WGS) INITIATIVE USING DNA FROM BLOOD SAMPLES IN OUR BIOSAMPLE REPOSITORY SEQUENCED AN ADDITIONAL 72 SAMPLES IN 2023, TOTALING 115 SAMPLES SINCE INCEPTION. THIS INITIATIVE SUPPORTS CLINICAL VALIDATION OF VARIANTS FOUND VIA WGS IN EITHER THE TSC1 OR TSC2 GENE, AND GENETIC RESULTS ARE OFFERED BACK TO PARTICIPANTS ALONG WITH A GENETIC COUNSELING SESSION FREE OF CHARGE TO THE FAMILY TO HELP THEM BETTER UNDERSTAND THEIR UNIQUE TSC DIAGNOSIS AND PROVIDE VALUABLE INFORMATION FOR FUTURE DECISION MAKING SUCH AS FAMILY PLANNING.IN DECEMBER 2021, THE TSC ALLIANCE ADDED THE TSC SELF-REPORT PORTAL TO THE TSC NATURAL HISTORY DATABASE. THIS PORTAL PERMITS THE COLLECTION OF PATIENT-REPORTED OUTCOMES ON HOW TSC AFFECTS INDIVIDUALS AND FAMILIES, WHICH WILL COMPLEMENT MEDICAL DATA IN THE NATURAL HISTORY DATABASE. THE PURPOSE OF THIS INITIATIVE IS TO HELP THE TSC ALLIANCE AND TSC RESEARCHERS BETTER UNDERSTAND THE PERSPECTIVE OF THOSE AFFECTED BY TSC TO DEVELOP TOOLS TO MEASURE IMPROVEMENT IN AREAS MOST IMPORTANT TO THE TSC COMMUNITY. EVENTUALLY, THESE MEASUREMENTS CAN BE USED TO IDENTIFY ENDPOINTS FOR CLINICAL TRIALS AND EVIDENCE-BASED GUIDELINES FOR TREATMENT.ONE OF THE MOST IMPACTFUL ASPECTS OF TSC ON THE QUALITY OF LIFE FOR PEOPLE LIVING WITH TSC IS TSC-ASSOCIATED NEUROPSYCHIATRIC DISORDERS (TAND). THEREFORE, THE TSC ALLIANCE'S FIRST USE OF THE PORTAL IS THROUGH COLLABORATION WITH THE TANDEM PROJECT (EMPOWERING FAMILIES THROUGH TECHNOLOGY: A MOBILE-HEALTH PROJECT TO REDUCE THE TAND IDENTIFICATION AND TREATMENT GAP) BY ALLOWING THE COMMUNITY TO COMPLETE THE SELF-QUANTIFIED TAND CHECKLIST (TAND-SQ). AT THE END OF 2023, 105 INDIVIDUALS WERE ENROLLED THROUGH THE SELF-REPORT PORTAL.THE TSC ALLIANCE LAUNCHED THE TSC PRECLINICAL CONSORTIUM IN 2015 TO HELP ADVANCE MORE DRUG CANDIDATES INTO CLINICAL TESTING. TO ACHIEVE THIS END, THE PRECLINICAL CONSORTIUM PROVIDES THE INFRASTRUCTURE TO FOSTER COLLABORATION BETWEEN ACADEMIA AND PHARMACEUTICAL INDUSTRY RESEARCHERS AND FOR ACCESS TO RESOURCES DESIGNED TO HELP FACILITATE DRUG DEVELOPMENT IN TSC. COLLABORATING WITH THE TSC COMMUNITY, THE CONSORTIUM HAS IDENTIFIED AND IMPLEMENTED ROBUST AND REPRODUCIBLE CELL AND ANIMAL MODELS FOR TSC MANIFESTATIONS INCLUDING TUMORS, EPILEPSY, AND TAND. IN 2022, THE TSC ALLIANCE ENTERED INTO A PARTNERSHIP WITH THE LAM FOUNDATION TO ADD LAM MOUSE MODELS TO THE PRECLINICAL CONSORTIUM. THE TSC ALLIANCE HAS LICENSES TO USE SPECIFIC TSC MOUSE MODELS FOR EXPERIMENTS CARRIED OUT BY THE PRECLINICAL CONSORTIUM, AND ALL MOUSE LICENSE AGREEMENTS INCLUDE THE RIGHTS FOR THE TSC ALLIANCE TO PERFORM EXPERIMENTS UNDER CONTRACT FOR COMMERCIAL ENTITIES. THIS ENSURES DATA GENERATED BY THE PRECLINICAL CONSORTIUM CAN BE USED TO ACCELERATE THE DEVELOPMENT OF NEW TREATMENTS BY COMMERCIAL ENTITIES AS WELL AS ACADEMIC INVESTIGATORS. EXPERIMENTS ARE EXECUTED AT PARTNERING RESEARCH INSTITUTIONS TO ENSURE CONSISTENCY IN TESTING, DATA ACQUISITION AND INTERPRETATION. EPILEPSY STUDIES ARE CONDUCTED AT PSYCHOGENICS (US), AND THE TUMOR GRAFT MODEL AND CELL-BASED ASSAYS ARE CONDUCTED AT PORSOLT (FRANCE). THE VAN ANDEL RESEARCH INSTITUTE, A NON-PROFIT RESEARCH ORGANIZATION, MAINTAINS A COLONY OF TSC2+/- AJ MICE AND F L7-CRE-TSC2 MICE ON BEHALF OF THE PRECLINICAL CONSORTIUM.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$895,227ExpenseAmt
DescSUPPORT SERVICES. SEE SCHEDULE O FOR FULL PROGRAM DESCRIPTION.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$554,030ExpenseAmt
DescPUBLIC HEALTH. SEE SCHEDULE O FOR FULL PROGRAM DESCRIPTION.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$287,855ExpenseAmt
DescGOVERNMENT RELATIONS EFFORTS FOCUS ON INCREASING FEDERAL AND STATE APPROPRIATIONS FOR TSC RESEARCH, RAISING AWARENESS, AND COLLABORATING WITH GOVERNMENT PARTNERS TO DRIVE TSC RESEARCH FORWARD AND IMPROVE CLINICAL CARE AND TREATMENT OPTIONS FOR INDIVIDUALS WITH TSC. ON THE STATE LEVEL, THE TSC ALLIANCE ADVOCATED FOR STATE FUNDING FOR TSC CENTERS IN ALABAMA, MISSOURI, AND MARYLAND, RESULTING IN AT LEAST $1.25 MILLION IN STATE APPROPRIATIONS. THE ANNUAL TSC ALLIANCE MARCH ON CAPITOL HILL TO ADVOCATE FOR FEDERAL FUNDING FOR THE TUBEROUS SCLEROSIS COMPLEX RESEARCH PROGRAM (TSCRP) AT THE DEPARTMENT OF DEFENSE'S (DOD) CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAM (CDMRP) TOOK PLACE IN EARLY MARCH 2023. ADVOCATES MET WITH MORE THAN 322 CONGRESSIONAL OFFICES VIRTUALLY AND IN PERSON TO ASK FOR $10 MILLION IN FUNDING FOR THE TSCRP. THE HOUSE TSCRP DEAR COLLEAGUE LETTER SPONSORED BY REPRESENTATIVES FITZPATRICK (R-PA) AND RASKIN (D-MD) CLOSED WITH 191SIGNERS. THE SENATE LETTER SPONSORED BY SENATORS CRAMER (R-ND) AND HEINRICH (D-NM) CLOSED WITH 41 SIGNERS. TOTAL FUNDING FOR THE TSCRP HAS BEEN $113 MILLION SINCE 2002, INCLUDING A $10 MILLION APPROPRIATION FOR FY234. RESEARCH PERFORMED THROUGH THIS PROGRAM HAS RECENTLY LED TO ADDITIONAL CLINICAL TRIALS INCLUDING DETERMINING IF IMATINIB, A DRUG FDA-APPROVED FOR CANCER, CAN SAFELY IMPROVE LEVELS OF VEGF-D, A BIOMARKER OF LYMPHANGIOLEIOMYOMATOSIS (LAM), A LIFE-THREATENING LUNG MANIFESTATION OF TSC, FUNDED IN FY2013; TWO TSCRP AWARDS IN FY2012 AND FY2015 THAT ENABLED GENERATION OF A POTENTIAL APPROACH FOR GENE THERAPY OF TSC, WHICH HAS SHOWN PROMISING RESULTS IN A MOUSE MODEL OF TSC TUMORS IN THE BRAIN; A MULTI-SITE CLINICAL TRIAL TESTING THE EFFICACY OF AN EXPERIMENTAL TOPICAL RAPAMYCIN CREAM TO TREAT THE DISFIGURING FACIAL TUMORS, CALLED FACIAL ANGIOFIBROMAS, CAUSED BY TSC FUNDED IN FY2010 THAT LED THE THIRD FDA-APPROVED DRUG TO TREAT TSC IN APRIL 2022; AND A CLINICAL RESEARCH NETWORK THAT WAS CREATED TO TEST POTENTIAL NEW THERAPIES, TO VALIDATE BIOMARKERS, AND TO LEARN THE NATURAL HISTORY OF LEADING TO A CLINICAL TRIAL FUNDED IN FY2012. DATA OBTAINED FROM AN FY2010 TSCRP CLINICAL RESEARCH AWARD TO DEFINE EARLY AUTISM PREDICTORS IN TSC AND AN FY2014 TSCRP AWARD FOR A PILOT CLINICAL TRIAL IS BEING TESTED IN A LARGE, NIH-FUNDED CLINICAL TRIAL LOOKING AT THE EFFECTIVENESS OF A BEHAVIORAL INTERVENTION STRATEGY, JASPER, TO IMPROVE OUTCOMES IN CHILDREN WITH AUTISM. THE TSCRP HAS ALSO FUNDED RESEARCH TO DEVELOP ANIMAL MODELS OF TSC THAT HAVE SEIZURES, ENABLING A BETTER UNDERSTANDING OF THE ETIOLOGY OF TSC. BASED ON DATA FROM TSCRP-FUNDED ANIMAL MODELS OF TSC THAT HAVE SEIZURES AND SHARE PATHOLOGY RELATED TO THAT OF TRAUMATIC BRAIN INJURY, AN INDUSTRY-SPONSORED CLINICAL TRIAL DEMONSTRATED THE EFFECTIVENESS THE MTOR INHIBITOR, EVEROLIMUS, AT TREATING EPILEPSY IN MANY INDIVIDUALS WITH TSC. NONE OF THIS PROGRESS WOULD HAVE BEEN POSSIBLE WITHOUT THE CRITICAL SUPPORT PROVIDED THROUGH THE TSCRP.GLOBAL OUTREACH WORKS TO ADDRESS UNMET NEEDS WITHIN THE GLOBAL TSC COMMUNITY. THE PROGRAM PROVIDES THE OPPORTUNITY FOR THE TSC ALLIANCE TO SHARE EXPERIENCES AND ASSIST IN THE START-UP OF SUPPORT OF TSC-RELATED ORGANIZATIONS IN OTHER COUNTRIES. A GLOBAL ALLIANCE IS A STRUCTURED GROUP OF EMPOWERED AND CARING VOLUNTEERS WHO WORK CLOSELY WITH THE TSC ALLIANCE TO FACILITATE LOCAL CONNECTIONS FOR INDIVIDUALS AND FAMILIES AFFECTED BY TSC AND RAISE REVENUE AND AWARENESS WHILE SUPPORTING THE MISSION OF THE ORGANIZATION. THE TSC ALLIANCE HAS SIX GLOBAL PARTNERSHIPS, INCLUDING TSC ALLIANCE OF ISRAEL, TS CANADA ST, TSC ALLIANCE OF MEXICO, TSC ALLIANCE FOUNDATION (IN THAILAND), HUNGARIAN FOUNDATION FOR TUBEROUS SCLEROSIS, AND TSC ALLIANCE OF INDIA. THE TSC ALLIANCE RECOGNIZES 13 TSC CLINICS IN GLOBAL ALLIANCE COUNTRIES. PROFESSIONAL EDUCATION EXPANDS PROGRAMS TO TARGET RESEARCHERS AND HEALTHCARE PROVIDERS CARING FOR INDIVIDUALS WITH TSC, MEDICAL STUDENTS, GENETIC COUNSELORS AND EDUCATORS TO MINIMIZE THE CONSEQUENCES OF IGNORANCE AND MISINFORMATION. THE TSC ALLIANCE EXHIBITED AT THE AMERICAN EPILEPSY SOCIETY ANNUAL MEETING. STAFF MEMBERS AND A VOLUNTEER SHARED EDUCATIONAL MATERIALS WITH ATTENDEES WHO VISITED THE BOOTH. STAFF ALSO PARTICIPATED IN THE TSC SPECIAL INTEREST GROUP SESSION, AND THE TSC ALLIANCE HOSTED MORE THAN 100 PEOPLE AT A RECEPTION WITH PRESENTATIONS BY PARENTS OF A CHILD WITH TSC AND BY DR. ANGELIQUE BORDEY, WHO DESCRIBED HOW TSC ALLIANCE HAS IMPACTED HER RESEARCH. THE TSC ALLIANCE PARTICIPATED IN OR PRESENTED AT 26 PROFESSIONAL MEETINGS IN 2023 INCLUDING PRETOLA COURSE, RESEARCH AMERICA ANNUAL ADVOCACY AWARDS, WOMEN AT BRIDGE LEADERSHIP SPEAKING SERIES, INSITRO TOWN HALL, RARE DISEASE INNOVATION AND PARTNERING SUMMIT, ANYA'S ACCELERATOR WORKSHOP, NORD, TSC ALLIANCE MEXICO BRIEFING, EAN CONGRESSIONAL BRIEFING, ATS ANNUAL MEETING, INTERAGENCY COLLABORATIVE TO ADVANCE RESEARCH IN EPILEPSY (ICARE), RARE DISEASES INTERNATIONAL WORLD HEALTH ASSEMBLY, UCP ANNUAL CONFERENCE, MARINUS TOWN HALL, TANDEM MINI SYMPOSIUM, ETSC WORKSHOP, NINDS NONPROFIT FORUM, CRISIS INTERVENTION TRAINING INTERNATIONAL, TSCI WORKSHOP, TSC REPRODUCTIVE & PERINATAL TASK FORCE MEETING, LGS MEETING, GLOBAL GENES RARE SUMMIT, PCORI ANNUAL MEETING, APERTURA TOWN HALL, RDCRN FALL MEETING, AES, AND EAN BRIEFING.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$287,855TotalOtherProgSrvcExpenseAmt
Total Program Service Expenses$6,759,393TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (1)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other AssetsYes (1)ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document33IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee26EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members30GoverningBodyVotingMembersCnt
Independent Voting Member30IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local ChaptersYes (1)LocalChaptersInd
Policies Reference ChaptersYes (1)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldINStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1TSC ALLIANCEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone3015629890PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line18737 COLLESVILLE ROAD 400AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (37 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
WILLIAM JOSEPH
CHAIR5.00Yes (X)Yes (X)$0$0$0
PAUL WAXLAX
VICE-CHAIR5.00Yes (X)Yes (X)$0$0$01.00
BRITTANY SMITH
TREASURER5.00Yes (X)Yes (X)$0$0$01.00
LESLEY HOLMES
SECRETARY2.00Yes (X)Yes (X)$0$0$0
PETER CRINO
IMMEDIATE PAST CHAIR2.00Yes (X)$0$0$0
DEREK BAUER
BOARD MEMBER2.00Yes (X)$0$0$0
JULIE BLUM
BOARD MEMBER2.00Yes (X)$0$0$0
MATT BOLGER
BOARD MEMBER2.00Yes (X)$0$0$0
CHIP BURKHALTER
BOARD MEMBER2.00Yes (X)$0$0$0
LISA CARLTON
BOARD MEMBER2.00Yes (X)$0$0$0
DAVID COIT
BOARD MEMBER2.00Yes (X)$0$0$0
MARK CARROLL
BOARD MEMBER2.00Yes (X)$0$0$0
JULIAN GANGOLLI
BOARD MEMBER2.00Yes (X)$0$0$0
TANJALA GIPSON
BOARD MEMBER2.00Yes (X)$0$0$0
JONATHAN GOLDSTEIN
BOARD MEMBER2.00Yes (X)$0$0$0
STEVEN GOLDSTEIN
BOARD MEMBER2.00Yes (X)$0$0$0
ROB GRANDIA
BOARD MEMBER2.00Yes (X)$0$0$0
DANA HOLINKA
BOARD MEMBER2.00Yes (X)$0$0$0
SHAFALI JESTE
BOARD MEMBER2.00Yes (X)$0$0$0
JESSICA KREFTING
BOARD MEMBER2.00Yes (X)$0$0$0
DARCY KRUEGER
BOARD MEMBER2.00Yes (X)$0$0$0
PATROSKI LAWSON
BOARD MEMBER2.00Yes (X)$0$0$0
KRISTI LENGYEL
BOARD MEMBER2.00Yes (X)$0$0$0
HEATHER LENS
BOARD MEMBER2.00Yes (X)$0$0$0
LAURA MARKS
BOARD MEMBER2.00Yes (X)$0$0$0
DIANE MCSWAIN
BOARD MEMBER2.00Yes (X)$0$0$0
MUSTAFA SAHIN
BOARD MEMBER2.00Yes (X)$0$0$0
SEAN SHILLINGER
BOARD MEMBER2.00Yes (X)$0$0$0
VANESSA VAZQUEZ
BOARD MEMBER2.00Yes (X)$0$0$0
TARA ZIMMERMAN
BOARD MEMBER2.00Yes (X)$0$0$0
KARI LUTHER ROSBECK
PRESIDENT & CEO54.00Yes (X)$223,746$2,260$29,4171.00
CYNTHIA ARCURI
CHIEF FINANCIAL OFFICER42.00Yes (X)$176,989$9,315$9,4821.00
STEVEN ROBERDS
CHIEF SCIENTIFIC OFFICER45.00$237,208$0$26,563Yes (X)
DEAN RAGER-AGUIAR
VICE PRESIDENT, TRANSLATIONAL RESEARCH45.00$177,725$0$28,091Yes (X)
LISA MOSS
VICE PRESIDENT, DONOR RELATIONS45.00$124,914$0$24,144Yes (X)
JAYE ISHAM
CHIEF OUTREACH OFFICER45.00$137,218$0$5,426Yes (X)
ASHLEY POUNDERS
DIRECTOR OF MEDICAL AFFAIRS45.00$115,372$0$13,076Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$1,193,172TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$11,575TotReportableCompRltdOrgAmt
Total Other Compensation$136,199TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K7IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (3 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
PSYCHOGENICS INC
20 GRAMERCY PARK SNEW YORKNY10003RESEARCH LAB SERVICES$1,565,754
VAN ANDEL RESEARCH INSTITUTE
333 BOSTWICK AVE NEGRAND RAPIDSMI49503RESEARCH LAB SERVICES$493,453
CAVAROCCHI RUSCIO DENNIS & ASSOCIATES
600 MARYLAND AVE SW SUITE 220 EASTWASHINGTONDC20024GOVERNMENT RELATIONS$117,714
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K3CntrctRcvdGreaterThan100KCnt
Federated Campaigns$40,093FederatedCampaignsAmt
Membership Dues$1,100MembershipDuesAmt
Fundraising$1,179,453FundraisingAmt
Related Organizations$572,625RelatedOrganizationsAmt
All Other Contributions$4,954,677AllOtherContributionsAmt
Total Contributions$6,747,948TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtExclusionExclusionAmt
CONTRACT REVENUE900099$2,548,976$2,548,976
CONFERENCE REVENUE900099$266,377$72,377$194,000
FieldValueIRS element (for citing)
Total Program Service Revenue$2,815,353TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$36,732TotalRevenueColumnAmt
Exclusion$36,732ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$258,687FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$1,179,453ContriRptFundraisingEventAmt
Fundraising Direct Expenses$164,132FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$94,555TotalRevenueColumnAmt
Exclusion$94,555ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescCHANGE IN INTEREST OF AFFILIATEDesc
Business900099BusinessCd
Total Revenue Column$320,800TotalRevenueColumnAmt
Exclusion$320,800ExclusionAmt

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$995TotalRevenueColumnAmt
Exclusion$995ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$321,795OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$10,016,383TotalRevenueColumnAmt
Related Or Exempt Func Income$2,621,353RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$647,082ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$696,542TotalAmt
Program Services$696,542ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$148,750TotalAmt
Program Services$148,750ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$703,405TotalAmt
Program Services$439,278ProgramServicesAmt
Management And General$102,064ManagementAndGeneralAmt
Fundraising$162,063FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$1,867,712TotalAmt
Program Services$1,166,420ProgramServicesAmt
Management And General$271,060ManagementAndGeneralAmt
Fundraising$430,232FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$52,530TotalAmt
Program Services$33,680ProgramServicesAmt
Management And General$5,461ManagementAndGeneralAmt
Fundraising$13,389FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$222,386TotalAmt
Program Services$142,119ProgramServicesAmt
Management And General$24,273ManagementAndGeneralAmt
Fundraising$55,994FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$178,343TotalAmt
Program Services$113,532ProgramServicesAmt
Management And General$20,556ManagementAndGeneralAmt
Fundraising$44,255FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$17,690TotalAmt
Program Services$11,342ProgramServicesAmt
Management And General$2,750ManagementAndGeneralAmt
Fundraising$3,598FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$23,250TotalAmt
Program Services$14,907ProgramServicesAmt
Management And General$3,614ManagementAndGeneralAmt
Fundraising$4,729FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$116,364TotalAmt
Program Services$74,606ProgramServicesAmt
Management And General$18,090ManagementAndGeneralAmt
Fundraising$23,668FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$219,360TotalAmt
Program Services$140,642ProgramServicesAmt
Management And General$34,102ManagementAndGeneralAmt
Fundraising$44,616FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$8,473TotalAmt
Program Services$5,492ProgramServicesAmt
Management And General$9ManagementAndGeneralAmt
Fundraising$2,972FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$328,107TotalAmt
Program Services$172,198ProgramServicesAmt
Management And General$9,714ManagementAndGeneralAmt
Fundraising$146,195FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$161,819TotalAmt
Program Services$80,801ProgramServicesAmt
Management And General$15,642ManagementAndGeneralAmt
Fundraising$65,376FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$144,753TotalAmt
Program Services$91,950ProgramServicesAmt
Management And General$16,592ManagementAndGeneralAmt
Fundraising$36,211FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$352,743TotalAmt
Program Services$294,269ProgramServicesAmt
Management And General$5,315ManagementAndGeneralAmt
Fundraising$53,159FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$447,239TotalAmt
Program Services$404,633ProgramServicesAmt
Management And General$7,811ManagementAndGeneralAmt
Fundraising$34,795FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$69,312TotalAmt
Program Services$52,790ProgramServicesAmt
Management And General$5,255ManagementAndGeneralAmt
Fundraising$11,267FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$13,070TotalAmt
Program Services$8,319ProgramServicesAmt
Management And General$1,511ManagementAndGeneralAmt
Fundraising$3,240FundraisingAmt

Other Expenses OtherExpensesGrp (3 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
PRECLINICAL CONSORTIUM$2,321,442$2,321,442
NHD BIOSAMPLE REPOSIT$328,386$328,386
DUES AND SUBSCRIPTIONS$39,981$13,730$12,520$13,731

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$5,991TotalAmt
Program Services$3,565ProgramServicesAmt
Management And General$1,625ManagementAndGeneralAmt
Fundraising$801FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$8,467,648TotalAmt
Program Services$6,759,393ProgramServicesAmt
Management And General$557,964ManagementAndGeneralAmt
Fundraising$1,150,291FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$43,084TotalAmt
Program Services$21,542ProgramServicesAmt
Management And General$21,542ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,711,209BOYAmt
EOY$1,487,710EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$694,859BOYAmt
EOY$700,650EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$5,280,316BOYAmt
EOY$4,306,013EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$181,490BOYAmt
EOY$350,534EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$277,696BOYAmt
EOY$283,821EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$811,270LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$417,309LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$463,272BOYAmt
EOY$393,961EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
EOY$1,752,986EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$6,219,095BOYAmt
EOY$6,810,093EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$14,827,937BOYAmt
EOY$16,085,768EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$891,501BOYAmt
EOY$813,246EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$285,264BOYAmt
EOY$189,493EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,196,326BOYAmt
EOY$1,085,681EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$2,373,091BOYAmt
EOY$2,088,420EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$5,151,339BOYAmt
EOY$6,372,958EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$7,303,507BOYAmt
EOY$7,624,390EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$12,454,846BOYAmt
EOY$13,997,348EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$14,827,937BOYAmt
EOY$16,085,768EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$1,548,735ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$6,233NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,527,543CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$4,345,011CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,769,053CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$7,016,851CurrentTaxYearMinus1YearAmt
Current Tax Year$6,496,698CurrentTaxYearAmt
Total$29,155,156TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,527,543CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$4,345,011CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,769,053CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$7,016,851CurrentTaxYearMinus1YearAmt
Current Tax Year$6,496,698CurrentTaxYearAmt
Total$29,155,156TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$4,732,702SubstantialContributorsTotAmt
Public Support Total170$24,422,454PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$27,444CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$11,188CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,809CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$2,382CurrentTaxYearMinus1YearAmt
Current Tax Year$36,732CurrentTaxYearAmt
Total$81,555TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$714CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus1 Year$15,492CurrentTaxYearMinus1YearAmt
Current Tax Year$995CurrentTaxYearAmt
Total$17,201TotalAmt
FieldValueIRS element (for citing)
Total Support$29,253,912TotalSupportAmt
Gross Receipts Rltd Activities$10,557,404GrossReceiptsRltdActivitiesAmt
Public Support CY1700.83480PublicSupportCY170Pct
Public Support PY1700.82010PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,345FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$187,396FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$188,741FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$7,128,616FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$7,317,357FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$515,868FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$128,967FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$423,685CurrentYearMinus3Amt
Current Year Minus2$497,465CurrentYearMinus2Amt
Current Year Minus1$550,968CurrentYearMinus1Amt
Current Year$515,868CurrentYearAmt
Total$1,987,986TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$2,981,979LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$123,014CurrentYearMinus3Amt
Current Year Minus2$154,139CurrentYearMinus2Amt
Current Year Minus1$162,771CurrentYearMinus1Amt
Current Year$188,741CurrentYearAmt
Total$628,665TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$105,921CurrentYearMinus3Amt
Current Year Minus2$124,366CurrentYearMinus2Amt
Current Year Minus1$137,742CurrentYearMinus1Amt
Current Year$128,967CurrentYearAmt
Total$496,996TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$745,494GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$895CurrentYearMinus3Amt
Current Year Minus2$1,127CurrentYearMinus2Amt
Current Year Minus1$1,395CurrentYearMinus1Amt
Current Year$1,345CurrentYearAmt
Total$4,762TotalAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,500,387BeginningYearBalanceAmt
Contributions$141,816ContributionsAmt
Investment Earnings Or Losses$812,509InvestmentEarningsOrLossesAmt
Other Expenditures$572,625OtherExpendituresAmt
Administrative Expenses$60,900AdministrativeExpensesAmt
End Year Balance$5,821,187EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$6,711,748BeginningYearBalanceAmt
Contributions$68,423ContributionsAmt
Investment Earnings Or Losses-$860,036InvestmentEarningsOrLossesAmt
Other Expenditures$238,000OtherExpendituresAmt
Administrative Expenses$181,748AdministrativeExpensesAmt
End Year Balance$5,500,387EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,893,521BeginningYearBalanceAmt
Contributions$132,476ContributionsAmt
Investment Earnings Or Losses$1,053,588InvestmentEarningsOrLossesAmt
Other Expenditures$333,813OtherExpendituresAmt
Administrative Expenses$34,024AdministrativeExpensesAmt
End Year Balance$6,711,748EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,915,805BeginningYearBalanceAmt
Contributions$54,645ContributionsAmt
Investment Earnings Or Losses$416,431InvestmentEarningsOrLossesAmt
Other Expenditures$463,721OtherExpendituresAmt
Administrative Expenses$29,639AdministrativeExpensesAmt
End Year Balance$5,893,521EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$5,193,934BeginningYearBalanceAmt
Contributions$78,962ContributionsAmt
Investment Earnings Or Losses$959,121InvestmentEarningsOrLossesAmt
Other Expenditures$288,356OtherExpendituresAmt
Administrative Expenses$27,856AdministrativeExpensesAmt
End Year Balance$5,915,805EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.83606BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.15789PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.00605TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgYes (1)EndowmentsHeldRelatedOrgInd
Related Org List Sch RYes (1)RelatedOrgListSchRInd

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$449,272OtherCostOrOtherBasisAmt
Depreciation$153,160DepreciationAmt
Book Value$296,112BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$281,726OtherCostOrOtherBasisAmt
Depreciation$183,877DepreciationAmt
Book Value$97,849BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$80,272OtherCostOrOtherBasisAmt
Depreciation$80,272DepreciationAmt
Book Value$0BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$393,961TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (3 entries)

DescDescBook ValueBookValueAmt
NET ASSETS OF AFFILIATE$5,821,187
OPERATING LEASE RIGHT-OF-USE ASSET$654,282
DUE FROM AFFILIATE$334,624
FieldValueIRS element (for citing)
Total Book Value Other Assets$6,810,093TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
OPERATING LEASE LIABILITY$1,084,988
DUE FROM RELATED PARTY$693
FieldValueIRS element (for citing)
Total Liability$1,085,681TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$10,024,868TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$6,233NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$14,718DonatedServicesAndUseFcltsAmt
Revenue Not Reported$8,485RevenueNotReportedAmt
Revenue Subtotal$10,016,383RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$10,016,383TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$8,482,366TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$14,718DonatedServicesUseFcltsAmt
Expenses Not Reported$14,718ExpensesNotReportedAmt
Expenses Subtotal$8,467,648ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$8,467,648TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART V, LINE 4:THE ALLIANCE'S ENDOWMENTS CONSIST OF TWO FUNDS ESTABLISHED FOR DIFFERENT PURPOSES. THE ALLIANCE'S ENDOWMENTS INCLUDE ONE TRADITIONAL DONOR-RESTRICTED ENOWMENT FUND AND ONE BOARD-DESIGNATED ENDOWMENT FUND. THE BOARD-DESIGNATED ENDOWMENT FUND SOLELY CONSISTS OF THE ENDOWMENT FUND'S UNRESTRICTED NET ASSET BALANCE.
PART XII, LINE 2D - OTHER ADJUSTMENTS:ROUNDING
PART XII, LINE 4B - OTHER ADJUSTMENTS:FUNDRAISING EXPENSES INCLUDED ON PART VIII

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp

FieldValueIRS element (for citing)
RegionEUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUMRegionTxt
Offices3OfficesCnt
Employee0EmployeeCnt
Type Of Activities ConductedGRANTS TO RECIPIENTS LOCATED IN REGIONTypeOfActivitiesConductedTxt
Specific Services ProvidedRESEARCH GRANTSSpecificServicesProvidedTxt
Region Total Expenditures$148,750RegionTotalExpendituresAmt
FieldValueIRS element (for citing)
Subtotal Offices3SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office3TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$148,750SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$148,750TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (4 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtNon Cash AssistanceNonCashAssistanceAmt
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUMRESEARCH ON TUBEROUS SCLEROSIS COMPLEX$18,750WIRE TRANSFER$0
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUMRESEARCH ON TUBEROUS SCLEROSIS COMPLEX$75,000WIRE TRANSFER$0
MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT,RESEARCH$8,500WIRE TRANSFER$0
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUMYOUNG INVESTIGATOR FELLOWSHIP AWARD$27,500WIRE TRANSFER$0
FieldValueIRS element (for citing)
Total501c3 Org0Total501c3OrgCnt
Total Other Org4TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationGRANTEE ORGANIZATIONS ARE EXPECTED TO FILE ANNUAL PROGRESS REPORTS TO OUTLINED GRANT GOALS AND MILESTONES. THESE REPORTS ARE REVIEWED BY A COMMITTEE OF PEERS. THIS COMMITTEE MAKES DETERMINATIONS BASED ON QUALITY OF WORK TO GOALS AND IF THE GRANTEE WILL CONTINUE TO RECEIVE FUNDING. A FINAL WRITTEN AND FINANCIAL REPORT IS REQUIRED OF ALL GRANTEES.ExplanationTxt

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1WALK-RUN-RIDE EVENTSEvent1Nm
Gross Receipts Event1$789,897GrossReceiptsEvent1Amt
Charitable Contri Event1$789,897CharitableContriEvent1Amt
Non Cash Prizes Event1$44,986NonCashPrizesEvent1Amt
Rent Facility Costs Event1$6,147RentFacilityCostsEvent1Amt
Food And Beverage Event1$8,314FoodAndBeverageEvent1Amt
Entertainment Event1$12,797EntertainmentEvent1Amt
Event2COMEDY FOR A CUREEvent2Nm
Gross Receipts Event2$464,844GrossReceiptsEvent2Amt
Charitable Contri Event2$389,556CharitableContriEvent2Amt
Gross Revenue Event2$75,288GrossRevenueEvent2Amt
Non Cash Prizes Event2$1,128NonCashPrizesEvent2Amt
Rent Facility Costs Event2$28,633RentFacilityCostsEvent2Amt
Food And Beverage Event2$44,988FoodAndBeverageEvent2Amt
Entertainment Event2$2,969EntertainmentEvent2Amt
Other Events Total8OtherEventsTotalCnt
Gross Receipts Other Events$183,399GrossReceiptsOtherEventsAmt
Gross Revenue Other Events$183,399GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events$2,478NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events$8,699RentFcltyCostsOtherEventsAmt
Oth Direct Expnss Other Events$2,993OthDirectExpnssOtherEventsAmt
Gross Receipts Total$1,438,140GrossReceiptsTotalAmt
Charitable Contributions Tot$1,179,453CharitableContributionsTotAmt
Gross Revenue Total Events$258,687GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events$48,592NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$43,479RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$53,302FoodAndBeverageTotalEventsAmt
Entertainment Total Events$15,766EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$2,993OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$164,132DirectExpenseSummaryEventsAmt
Net Income Summary$94,555NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (13 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
BAYLOR COLLEGE OF MEDICINE
PO BOX 301207DALLASTX70690741613878501(C)(3)$18,750$0RESEARCH GRANT
BRIGHAM & WOMEN'S HOSPITAL
POB 3149BOSTONMA02241042312909501(C)(3)$56,250$0RESEARCH GRANT
UNIVERSITY OF VIRGINIA
1001 N EMMET STCHARLOTTESVILLEVA22903546001796501(C)(3)$18,750$0RESEARCH GRANT
NATIONAL ORGANIZATION FOR RARE DISORDERS
DEPT 5430 PO BOX 4110WOBURNMA01888133223946501(C)(3)$125,000$0TSC TRAVEL AND LODGING ASSISTANCE PROGRAM
UNIVERSITY OF CALIFORNIA
10889 WILSHIRE BLVD SUITE 700LOS ANGELESCA90095956006143501(C)(3)$20,000$0RESEARCH GRANT
COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
615 W 131ST STREET 6TH FLOOR MAILNEW YORKNY10027135598093501(C)(3)$75,000$0RESEARCH GRANTCODE 8725
UNIVERSITY OF CALIFORNIA IRVINE
228 ALDRICH HALLIRVINECA92697952226406501(C)(3)$18,750$0RESEARCH GRANT
UNIVERSITY OF MARYLAND BALTIMORE
PO BOX 41428BALTIMOREMD21203526002033501(C)(3)$56,250$0RESEARCH GRANT
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
5323 HARRY HINES BLVDDALLASTX75390756002868501(C)(3)$56,250$0RESEARCH GRANT
UNIVERSITY OF TEXAS DALLAS
800 WEST CAMPBEL ROAD SP2 27RICHARDSONTX75080751305566501(C)(3)$18,750$0RESEARCH GRANT
UNIVERSITY OF ALABAMA BIRMINGHAM
1720 2ND AVE SOUTH AB990BIRMINGHAMAL32294636005396501(C)(3)$91,649$0RESEARCH GRANT
UNIVERSITY OF NEW ENGLAND
11 HILLS BEACH RD ROOM 207BIDDEFORDME04005010211810501(C)(3)$20,000$0RESEARCH GRANT
BOSTON CHILDREN'S HOSPITAL
PO BOX 414413BOSTONMA02241042774441501(C)(3)$57,409$0RESEARCH GRANT
FieldValueIRS element (for citing)
Total501c3 Org13Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationTHE TSC ALLIANCE HAS FUNDED $37 MILLION IN RESEARCH ON TSC SINCE 1984. DIRECTED BY STEVEN L. ROBERDS, PH.D, CHIEF SCIENTIFIC OFFICER, THE TSC ALLIANCE RESEARCH GRANTS PROGRAM FUNDS RESEARCH FOCUSED ON TSC WITH PRIORITIES SET BY THE RESEARCHERS TOGETHER WITH THE TSC ALLIANCE. COLLABORATIONS BETWEEN BASIC AND CLINICAL RESEARCHERS ARE ENCOURAGED AND FOSTERED, AND THE TSC ALLIANCE IS WORKING TO INCREASE FUNDING FOR RESEARCH ON TSC. THROUGH THE TSC ALLIANCE RESEARCH GRANTS PROGRAM, APPLICATIONS CAN BE SUBMITTED FOR POSTDOCTORAL FELLOWSHIPS AND TSC RESEARCH GRANTS. GRANTS ARE REVIEWED IN A THREE-STEP PROCESS: 1. A GRANT REVIEW COMMITTEE COMPOSED OF INDIVIDUALS KNOWLEDGEABLE ABOUT THE CLINICAL AND BASIC COMPONENTS OF TSC AS WELL AS CONSUMERS REVIEW ALL GRANT APPLICATIONS FOR SCIENTIFIC MERITS, RELEVANCY TO THE FUNDING PRIORITIES OF THE ORGANIZATION AND WITH A FOCUS ON UNDERSTANDING THE MECHANISMS OF TSC AND/OR THE DEVELOPMENT OF TREATMENTS AND THERAPIES FOR THE MANIFESTATIONS OF THE DISEASE. 2. THE SCIENCE AND MEDICAL COMMITTEE OF THE BOARD OF DIRECTORS THEN REVIEWS THE GRANT REVIEW COMMITTEE'S CONCLUSIONS AND MAKES FUNDING RECOMMENDATIONS TO THE BOARD OF DIRECTORS. 3. THE BOARD OF DIRECTORS THEN REVIEWS THE RECOMMENDATIONS OF THE SCIENCE AND MEDICAL COMMITTEE AND MAKES FINAL APPROVAL FOR THE FUNDING OF GRANTS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgYes (1)CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgYes (1)CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (4 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
STEVEN ROBERDS
CHIEF SCIENTIFIC OFFICER$214,711$0$22,497$0$0$0$7,291$0$19,272$0$263,771$0$0$0
KARI LUTHER ROSBECK
PRESIDENT & CEO$201,924$2,040$21,822$220$0$0$7,012$0$22,405$0$253,163$2,260$0$0
DEAN RAGER-AGUIAR
VICE PRESIDENT, TRANSLATIONAL RESEAR$159,369$0$18,356$0$0$0$5,660$0$22,431$0$205,816$0$0$0
CYNTHIA ARCURI
CHIEF FINANCIAL OFFICER$161,389$8,494$15,600$821$0$0$5,588$0$3,894$0$186,471$9,315$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 5KARI LUTHER ROSBECK, STEVE ROBERDS, CYNTHIA ARCURI, DEAN AGUIAR, JAYE ISHAM, LISA MOSS, AND ASHLEY POUNDERS ALL HAVE INCENTIVE COMPENSATION EQUAL TO A PERCENTAGE OF THEIR SALARIES BASED ON KEY PERFORMANCE OBJECTIVES AS ESTABLISHED BY THEIR COMPENSATION COMMITTEE.
PART I, LINE 6KARI LUTHER ROSBECK, STEVE ROBERDS, CYNTHIA ARCURI, DEAN AGUIAR, JAYE ISHAM, LISA MOSS, AND ASHLEY POUNDERS ALL HAVE INCENTIVE COMPENSATION EQUAL TO A PERCENTAGE OF THEIR SALARIES BASED ON KEY PERFORMANCE OBJECTIVES AS ESTABLISHED BY THEIR COMPENSATION COMMITTEE.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (11 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE:THE PRECLINICAL CONSORTIUM INVITES COMPOUND NOMINATIONS FROM ACADEMIC AND INDUSTRY RESEARCHERS TO CONTINUE TO REFRESH OUR PIPELINE BASED ON THE LATEST DATA AND NOVEL IDEAS. THE NOMINATIONS ARE PEER REVIEWED BY CONSORTIUM MEMBERS AND PRIORITIZED BY THE PRECLINICAL CONSORTIUM STEERING COMMITTEE FOR FUNDING BY THE TSC ALLIANCE. IF THE TSC ALLIANCE FUNDS THE STUDY, THE DATA ARE SHARED WITH THE CONSORTIUM FOR TRANSPARENCY AND STIMULATION OF ADDITIONAL HYPOTHESES. A MEMBERS MEETING IS HELD ANNUALLY TO KEEP MEMBERS ENGAGED AND ALIGNED ON THE CONSORTIUM'S STRATEGY AND PRIORITIES. PARTNERSHIP WITH PHARMACEUTICAL COMPANIES IS AN IMPORTANT ASPECT OF THE CONSORTIUM, AS THESE ORGANIZATIONS HAVE THE INFRASTRUCTURE TO EFFICIENTLY MOVE PRECLINICAL RESEARCH FINDINGS TO CLINICAL TESTING AND EVENTUALLY COMMERCIAL DISTRIBUTION. IN 2023, TWO NEW INDUSTRY MEMBERS JOINED THE CONSORTIUM WITH A TOTAL OF 9 ACTIVE INDUSTRY MEMBERS AT THE END OF THE YEAR. THE CONSORTIUM HAS HAD 22 COMPANY MEMBERS SINCE 2016. THERE IS NATURAL TURNOVER OF INDUSTRY MEMBERSHIP, PRINCIPALLY DRIVEN BY RESEARCH DATA GENERATED BY TESTING THEIR DRUGS. DUE TO INTELLECTUAL PROPERTY CONSIDERATIONS, MOST COMPANIES FULLY FUND THEIR STUDIES THROUGH THE TSC ALLIANCE, WHICH ALLOWS THE COMPANY TO KEEP ITS DATA CONFIDENTIAL. THESE CONFIDENTIAL STUDIES ALSO INCUR A 10% OVERHEAD PAID BY THE COMPANY, WHICH IS A SOURCE OF REVENUE FOR THE TSC ALLIANCE. THE CONSORTIUM TESTED 17 UNIQUE COMPOUNDS IN 2023, RAISING THE TOTAL TESTED TO 82 SINCE 2016. MANY COMPOUNDS WILL ENTER PRECLINICAL TESTING, THOUGH ONLY SOME WILL ADVANCE TO CLINICAL TESTING DUE TO LACK OF EFFICACY AND SAFETY. IN 2012, THE TSC ALLIANCE HELPED CREATE THE TSC CLINICAL RESEARCH CONSORTIUM IN PARTNERSHIP WITH INVESTIGATORS RUNNING CLINICAL STUDIES TO ENSURE CLINICAL RESEARCH IN TSC IS AS EFFICIENT AND EFFECTIVE AS POSSIBLE. SINCE THEN, TSC CLINICAL RESEARCH CONSORTIUM INVESTIGATORS HAVE BEEN AWARDED MORE THAN $40 MILLION BY THE NATIONAL INSTITUTES OF HEALTH (NIH) AND FOOD AND DRUG ADMINISTRATION (FDA) THROUGH COMPETITIVE GRANT PROCESSES. TSC ALLIANCE PERSONNEL SERVE ON THE LEADERSHIP TEAM FOR THE CONSORTIUM, ACTIVELY TRACK ENROLLMENT, AND RAISE COMMUNITY AWARENESS TO HELP IDENTIFY POTENTIAL PARTICIPANTS FOR CLINICAL STUDIES. TSC ALLIANCE ALSO PROVIDES SUPPLEMENTAL FINANCIAL SUPPORT TO ACCELERATE OR EXPAND NIH-FUNDED STUDIES. THE PREVENT TRIAL PREVENTING EPILEPSY USING VIGABATRIN IN INFANTS WITH TSCWAS THE FIRST PREVENTATIVE TRIAL IN THE UNITED STATES FOR ANY FORM OF EPILEPSY. INITIAL RESULTS FROM THE STUDY WERE REPORTED THIS YEAR. IN THE PREVENT TRIAL, INFANTS WITH TSC RECEIVED REGULAR EEG MONITORING AND THOSE WHO DEVELOPED EEG ABNORMALITIES WERE PLACED ON EITHER VIGABATRIN (SUPPLIED BY LUNDBECK) OR A PLACEBO. ANY INFANT WHO SUBSEQUENTLY DEVELOPED CLINICAL SEIZURES WAS IMMEDIATELY PLACED ON STANDARD TREATMENT. RESULTS OF THE STUDY SHOWED THAT PREVENTATIVE TREATMENT WITH VIGABATRIN BEGINNING WHEN EEG BIOMARKER CHANGES WERE OBSERVED DELAYED THE ONSET AND LOWERED THE OVERALL OCCURRENCE OF INFANTILE SPASMS IN INFANTS WITH TSC. HOWEVER, THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN THE TREATMENT GROUP AND THE PLACEBO GROUP IN TERMS OF DRUG-RESISTANT EPILEPSY, FOCAL SEIZURES, OR COGNITIVE AND BEHAVIORAL OUTCOMES AT TWO YEARS OF AGE. IN THIS TRIAL, THE BIGGEST PREDICTOR OF POORER DEVELOPMENTAL OUTCOMES WAS THE AGE AT WHICH THE EEG BIOMARKER CHANGES OCCURRED: THOSE INFANTS WHOSE EEG CHANGES OCCURRED PRIOR TO SEVEN MONTHS OF AGE HAD, ON AVERAGE, LOWER COGNITIVE AND BEHAVIORAL SCORES THAN THOSE WHOSE EEG CHANGES OCCURRED LATER, REGARDLESS OF TREATMENT VIA VIGABATRIN VERSUS PLACEBO. THIS SUGGESTS THAT RAPID DIAGNOSIS OF TSC IN INFANTS, PRIOR TO HAVING ANY SEIZURES, FOLLOWED BY A CLOSE MONITORING AND RAPID INITIATION OF TREATMENT WHEN SEIZURES BEGIN IS CRITICAL FOR ENSURING THE BEST OUTCOMES POSSIBLE. MORE DETAILS ABOUT THIS STUDY ARE ONLINE AT WWW.CLINICALTRIALS.GOV/CT2/SHOW/NCT02849457. IMMEDIATELY AFTER THE PREVENT TRIAL ENROLLMENT COMPLETED, A SIMILAR CLINICAL TRIAL BEGAN ENROLLING NEWBORNS WITH TSC BEFORE THE ONSET OF SEIZURES TO TEST THE EFFECTS OF SIROLIMUS ON PREVENTING OR DELAYING SEIZURE ONSET. THE STOPPING TSC ONSET AND PROGRESSION 2 (STOP-2) TRIAL ENROLLED FIVE INFANTS AT CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER AS AN INITIAL SAFETY STUDY. THE SECOND STAGE OF THE TRIAL IS NOW CALLED "SIROLIMUS TSC EPILEPSY PREVENTION STUDY (TSC-STEPS) AND THE TSC ALLIANCE HAS CONTRIBUTED $200,000 TO ENABLE THE TRIAL TO BE EXPANDED TO ADDITIONAL SITES ACROSS THE COUNTRY. THE TSC ALLIANCE IS ALSO PROVIDING SUPPLEMENTAL FUNDING AND COLLECTING BLOOD SAMPLES FOR THE DEVELOPMENTAL SYNAPTOPATHIES CONSORTIUM (DSC), AN NIH-FUNDED PROJECT THAT INCLUDES STUDIES OF TSC AND THE RELATED RARE DISORDERS PHELAN-MCDERMID SYNDROME AND PTEN HAMARTOMA SYNDROME. THESE THREE RARE DISEASES SEEM TO AFFECT CERTAIN SHARED PATHWAYS INFLUENCING THE DEVELOPMENT OF BRAIN CONNECTIONS, OR SYNAPSES. RESEARCHERS IN THIS STUDY ARE TRYING TO FIND EARLIER SIGNS OF AUTISM SPECTRUM DISORDER (ASD) AND INTELLECTUAL DISABILITY (ID) TO GAIN A BETTER UNDERSTANDING OF ASD/ID IN INDIVIDUALS WITH TSC AND ENABLE EFFECTIVE TREATMENTS AND INTERVENTIONS FOR ASD/ID TO BE FOUND. THE DSC WAS RENEWED IN 2019 FOR A SECOND 5-YEAR FUNDING PERIOD. THE TSC ALLIANCE FUNDS A PORTION OF CLINICAL RESEARCH COORDINATORS' SALARIES AT 5 SITES. IN 2021, THE TSC ALLIANCE AWARDED A TWO-YEAR CLINICAL RESEARCH TSC-DSC FELLOWSHIP TO FELIX CHAN, PHD, AT BROWN UNIVERSITY WHO MOVED IN 2022 TO ASTON UNIVERSITY IN BIRMINGHAM, ENGLAND.
FORM 990, PART III, LINE 4B, DESCRIPTION OF PROGRAM SERVICE:SUPPORT SERVICES IS DEDICATED TO SUPPORTING INDIVIDUALS AND FAMILIES AFFECTED BY TSC THROUGH OUTREACH PROGRAMS, SUPPORT SERVICES, IMPROVED MEDICAL ACCESS, AND EDUCATIONAL RESOURCES. IN 2023, THE TSC ALLIANCE IMPLEMENTED A NEW COMMUNITY SUPPORT MODEL THAT PUTS THE TSC COMMUNITY CENTER FOCUSING ON LOCAL RESOURCES, SUPPORT SERVICES, AND ACCESS TO MEDICAL CARE IN CONJUNCTION WITH ENERGIZING THE CURRENT AND FUTURE VOLUNTEER LEADERS TO PROPEL THE TSC ALLIANCE TO THE NEXT LEVEL. THIS MODEL UNITED 36 COMMUNITY ALLIANCES AND ORGANIZED THEM INTO 15 COMMUNITY REGIONS, LED BY MORE THAN 150 DEDICATED LEADERS THROUGHOUT THE UNITED STATES. THE COMMUNITY PROGRAMS TEAM INVESTED MORE THAN 900 TRAINING HOURS TO OUR LEADERS, TO ENSURE THEY WERE WELL EQUIPPED TO SUPPORT AND EMPOWER THE TSC COMMUNITY. AS A RESULT, WE PROVIDED 4,278 PEER-TO-PEER SUPPORT ENGAGEMENTS AND FACILITATED 50 SCHOOL MEETINGS, WHICH INVOLVED TSC 101 TRAINING AND IEP CONSULTATIONS. IN ADDITION, TWO "ASK AN ADVOCATE" WEBINARS ATTRACTED 94 REGISTRANTS. THE COMMUNITY PROGRAMS TEAM COLLABORATED WITH KEY STAFF TO HOST SEVEN RESEARCH AND CORPORATE PARTNER WEBINARS. THESE WEBINARS ATTRACTED 312 LIVE ATTENDEES AND GARNERED 832 RECORDED VIEWS, WITH 801 LANDING PAGE VIEWS AS OF DECEMBER 31, 2023. THE TSC ALLIANCE ALSO PARTNERED WITH THE LAM FOUNDATION TO CO-HOST FOUR EDUCATIONAL CONFERENCE SERIES HELD IN SEATTLE, WA; DENVER, CO; BIRMINGHAM, AL; WASHINGTON, DC. THESE CONFERENCES ATTRACTED 350-PLUS PARTICIPANTS. THE TSC ALLIANCE'S TSC NAVIGATOR IS AN EASY-TO-USE, INTERACTIVE ONLINE TOOL TO HELP GUIDE INDIVIDUALS AND FAMILIES THROUGH THE COMPLEXITIES OF TSC ACROSS THE LIFESPAN, PROACTIVELY MANAGE THEIR CARE, AND LIVE THEIR FULLEST LIVES. USERS CAN ACCESS INFORMATION BASED ON THE AGE OF ONE'S DIAGNOSIS, SUCH AS PRENATAL, CHILDHOOD, OR ADULT, TO HELP DETERMINE WHICH STEPS WILL HELP EMPOWER THEM THROUGHOUT THEIR INDIVIDUAL JOURNEYS. IN 2023, THE TOOL HAD 2,379 USERS. EIGHT INDIVIDUALS OR FAMILIES WERE ALSO SUPPORTED FOR MEDICATION ACCESS ISSUES VIA OUR TSC NAVIGATOR PROGRAM DURING 2023, DOWN FROM 55 IN 2022, CONSISTENT WITH THE GOAL OF PROACTIVELY HELPING PEOPLE AVOID MEDICATION ACCESS ISSUES.
FORM 990, PART III, LINE 4C, DESCRIPTION OF PROGRAM SERVICE:PUBLIC HEALTH EDUCATION INCREASES AWARENESS OF TSC THROUGHOUT THE GENERAL PUBLIC TO BROADEN THE SCOPE OF SUPPORT AND UNDERSTANDING BEYOND TSC INDIVIDUALS AND THEIR FAMILIES; THESE EFFORTS ALSO WORK TO HELP REACH THE UNDIAGNOSED AND NEWLY DIAGNOSED. DURING 2023, THE TSC ALLIANCE PRODUCED TWO ISSUES OF ITS NATIONAL MAGAZINE, PERSPECTIVE, WHICH IS MAILED TO APPROXIMATELY 18,500 CONSTITUENTS AS WELL AS POSTED ON THE WEBSITE. THE TSC ALLIANCE'S PODCAST SERIES, CALLED TSC NOW, PRODUCED EIGHT EPISODES WITH 2,180 TOTAL LISTENS. FIVE ISSUES OF THE ELECTRONIC TSC MATTERS NEWSLETTER WERE DISTRIBUTED TO 17,514 RECIPIENTS. THE TSC ALLIANCE'S WEBSITE INCREASES AWARENESS AND PROVIDES EXTENSIVE EDUCATION THROUGH A MONTHLY AVERAGE OF 26,916 PAGE VIEWS. THE TSC ALLIANCE ALSO RELIES HEAVILY ON SOCIAL MEDIA TO EDUCATE CONSTITUENTS AND PROMOTE NEW RESOURCES AND EVENTS. ITS PRIVATE FACEBOOK TSC DISCUSSION GROUP BOASTS MORE THAN 10,800 MEMBERS FROM AROUND THE WORLD, WHILE ITS TWITTER ACCOUNT HAS 2,684 FOLLOWERS AND INSTAGRAM HAS 3,432 FOLLOWERS. TO INCREASE PUBLIC AWARENESS, THE TSC ALLIANCE PARTICIPATED IN THE 11TH ANNUAL TSC GLOBAL AWARENESS DAY ON MAY 15 AS WELL AS TSC AWARENESS MONTH THROUGHOUT MAY. THE TSC ALLIANCE ALSO HEAVILY PROMOTED INFANTILE SPASMS AWARENESS WEEK (DECEMBER 1 TO 7). THESE AWARENESS CAMPAIGNS ALONG WITH THE ORGANIZATION'S VARIOUS NEWS RELEASES AND SOCIAL MEDIA OUTREACH EFFORTS CULMINATED IN MORE THAN 812 MILLION CUMULATIVE IMPRESSIONS AND ENGAGEMENTS.
FORM 990, PART VI, SECTION A, LINE 6MEMBERSHIP IN THE CORPORATION IS AVAILABLE TO ANY PERSON WHO SUBSCRIBES TO THE PURPOSES AND OBJECTIVES OF THE CORPORATION, WITHOUT REGARD TO RACE, RELIGION, GENDER, SEXUAL ORIENTATION, AGE, COLOR, NATIONAL ORIGIN, OR MENTAL OR PHYSICAL HANDICAP OR DISABILITY. THERE IS NO LIMIT TO THE NUMBER OF MEMBERS IN THE CORPORATION. 1) THERE MAY BE ONE OR MORE CLASSES OF MEMBERSHIP AS DETERMINED BY THE BOARD. 2) MEMBERSHIP IS NOT TRANSFERABLE OR ASSIGNABLE.
FORM 990, PART VI, SECTION A, LINE 7ATHE TSC ALLIANCE IS A MEMBERSHIP-BASED ORGANIZATION, WHICH MEANS MEMBERS HELP ELECT THE BOARD OF DIRECTORS. THE TSC ALLIANCE MEMBERSHIP PROGRAM ALLOWS INDIVIDUALS TO STATE THEIR INTENT TO BE A MEMBER FOR THE PURPOSE OF GOVERNANCE. THERE WERE NO LEVELS TO MEMBERSHIP IN 2021. ANYONE CAN BE A MEMBER AT NO COST.
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 IS REVIEWED, IN DETAIL, BY THE BOARD OF DIRECTORS' AUDIT COMMITTEE. RECOMMENDATIONS ARE MADE BY THE COMMITTEE MEMBERS FOR ANY CHANGES/EDITS/ADDITIONS. AFTER THOSE HAVE BEEN INCORPORATED, THE AUDIT COMMITTEE VOTES WHETHER TO APPROVE AND THEN FORWARD THE 990 TO THE FINANCE AND EXECUTIVE COMMITTEES. THE FINANCE AND EXECUTIVE COMMITTEES PERFORM THE FINAL REVIEW AND THEN VOTE WHETHER TO APPROVE ON BEHALF OF THE BOARD OF DIRECTORS. A COPY OF THE APPROVED 990 IS SHARED WITH THE ENTIRE BOARD PRIOR TO ITS FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12C"ANNUALLY EACH MEMBER OF THE BOARD OF DIRECTORS WILL RECEIVE NOTICE OF THE ORGANIZATION'S CONFLICT OF INTEREST STATEMENT. EACH MEMBER WILL BE PROVIDED WITH A STATEMENT TO MAKE DISCLOSURE OF ANY POTENTIAL CONFLICT OF INTEREST. IF DURING THE COURSE OF THE YEAR A POTENTIAL CONFLICT OF INTEREST ARISES THAT HAS NOT PREVIOUSLY BEEN DISCLOSED, THE BOARD MEMBER WILL MAKE WRITTEN NOTICE OF A POTENTIAL CONFLICT OF INTEREST AND RECUSE HIMSELF OR HERSELF FROM ANY DISCUSSIONS AND VOTES IN CONNECTION WITH THE ISSUE IDENTIFIED. ANY TIME A MEMBER IS RECUSED FROM DISCUSSION ON AN ISSUE, THE MINUTES OF COMMITTEE MEETING AND BOARD MEETING WILL DULY RECORD SUCH ACTIONS. THE FOLLOWING POTENTIAL CONFLICTS OF INTEREST WERE DISCLOSED FOR 2023: BOARD MEMBER MUSTAFA SAHIN, PH.D., M.D., IS EMPLOYED AT BOSTON CHILDREN'S HOSPITAL, WHICH RECEIVED $57,409 IN GRANTS AND $6,300 IN FEES FOR SERVICES FOR PARTICIPATION IN THE TSC NATURAL HISTORY DATABASE. BOARD MEMBER DARCY KRUEGER, MD, MPA, IS EMPLOYED AT THE CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER, WHICH RECEIVED $3,420 IN FEES FOR SERVICES FOR PARTICIPATION IN THE TSC NATURAL HISTORY DATABASE. BOARD MEMBER JESSICA KREFTING, RN, IS EMPLOYED AT UNIVERSITY OF ALABAMA AT BIRMINGHAM, WHICH RECEIVED $91,649 IN GRANTS AND $9,010 IN FEES FOR SERVICES FOR PARTICIPATION IN THE TSC NATURAL HISTORY DATABASE. BOARD MEMBER AND IMMEDIATE PAST CHAIR PETER CRINO, MD, PHD, IS CHAIR OF THE DEPARTMENT OF NEUROLOGY AT THE UNIVERSITY OF MD, WHICH RECIEVED $56,250 OF GRANT PAYMENTS."
FORM 990, PART VI, SECTION B, LINE 15"THE COMPENSATION COMMITTEE REVIEWS AND APPROVES THE SALARIES OF THE PRESIDENT/CEO, CHIEF SCIENTIFIC OFFICER, CFO, AND ANY EMPLOYEE APPEARING ON THE FORM 990, IN ACCORDANCE WITH THE TSC ALLIANCE BYLAWS. SUCH REVIEW AND APPROVAL OCCURS INITIALLY UPON HIRING, UPON ANNUAL REVIEWS, AND WHENEVER MODIFIED. THE ORGANIZATION'S EXECUTIVE REMUNERATION HAS BEEN STRUCTURED TO ENSURE THAT IT: IS REASONABLE; PROVIDES A COMPETITIVE COMPENSATION PROGRAM TO RETAIN, ATTRACT AND REWARD KEY EMPLOYEES AND ACHIEVES CLEAR ALIGNMENT BETWEEN TOTAL REMUNERATION AND DELIVERED BUSINESS AND PERSONAL PERFORMANCE OVER THE SHORT AND LONG-TERMS. THE COMPENSATION IS REVIEWED BY THE COMPENSATION COMMITTEE TO ENSURE: - COMPARABILITY, - PROPER REVIEW, AND - SUBSTANTIATION IN SETTING THE COMPENSATION."
FORM 990, PART VI, SECTION C, LINE 19ALL GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON WRITTEN REQUEST.
FORM 990, PART XII, LINE 2C:THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.
FORM 990 AMENDED RETURNTHE FORM 990 WAS AMENDED TO INCLUDE THE JOINT COST ALLOCATION THAT WAS INADVERTENTLY LEFT OFF OF PART IX LINE 26.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1TSC ALLIANCE ENDOWMENT FUND INCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line18737 COLESVILLE ROAD NO 400AddressLine1Txt
CitySILVER SPRINGCityNm
State AbbreviationMDStateAbbreviationCd
ZIP20910ZIPCd
FieldValueIRS element (for citing)
EIN521926919EIN
Primary ActivitiesSUPPORT THE MISSION OF THE TSC ALLIANCEPrimaryActivitiesTxt
Legal Domicile StateMDLegalDomicileStateCd
Exempt Code Section501(C)(3)ExemptCodeSectionTxt
Public Charity StatusLINE 12B, IIPublicCharityStatusTxt
Direct Controlling NAN/ADirectControllingNACd
Controlled Organization0ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (1)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (1)SharingOfFacilitiesInd
Paid Employees SharingYes (1)PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp

Other Organization Name OtherOrganizationName

FieldValueIRS element (for citing)
Business Name Line1TSC ALLIANCE ENDOWMENT FUND INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Transaction TypeCTransactionTypeTxt
Involved$572,625InvolvedAmt
Method Of Amount DeterminationACTUAL CASH RECEIVEDMethodOfAmountDeterminationTxt

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.